There are 2789 resources available
171P - Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy
Presenter: Shu Yazaki
Session: ePoster Display
172P - Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)
Presenter: Guilherme Nader Marta
Session: ePoster Display
173P - What to expect from NCCN BRCA testing criteria: A retrospective cohort analysis
Presenter: Burak Aktas
Session: ePoster Display
174P - Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors
Presenter: Elif Isbilen
Session: ePoster Display
175P - Prosigna test for early breast cancer patients in real-life
Presenter: Delphine Hequet
Session: ePoster Display
176P - Pathological complete response to neoadjuvant systemic therapy in 1160 initial and locally advanced breast cancer patients: Real life data on outcomes
Presenter: Monique Tavares
Session: ePoster Display
Resources:
Abstract
177P - Pathogenicity reclassification of unknown significance variants related to early-onset breast cancer women of mongoloid origin
Presenter: Polina Gervas
Session: ePoster Display
178P - Age-related mutational landscape of luminal breast cancers
Presenter: Nawale Hajjaji
Session: ePoster Display
179P - Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin for early triple-negative breast cancer: A single-arm, open-label, phase II study
Presenter: Chengzheng Wang
Session: ePoster Display
180P - Relapse pattern after neoadjuvant treatment in early breast cancer
Presenter: Ariadna Gasol Cudos
Session: ePoster Display